INTRODUCTION
============

Nearly 70 million people worldwide suffer from ASD. 700,000 are from USA and the estimated cost to society of caring for these children has been \$11.5 billion in 2011 ([@B79]). ASD is a group of heterogeneous neurodevelopmental disorders previously dealt with as single pathologies: autistic disorder, pervasive developmental disorder-not otherwise specified (PDD-NOS), Asperger syndrome, childhood disintegrative disorder also known as Heller syndrome, and Rett syndrome. Specific impairments before age three, in each of the following three core domains fit the diagnostic criteria for ASD: ***social*** (difficulty in interacting with people, in reading facial expressions and making eye contact), ***language*** (difficulty in using or understanding language, tending to focus attention and conversation on a limited number of topics, frequently repeat phrases, and have very limited speech ability), and ***restricted/repetitive behavior*** (excessive attention to routines and difficulty in adjusting to new surroundings or changes in routine). Given the complexity of the disorder and the variety and severity of the symptoms, ASD is thought to be caused by multiple factors interacting in a complex way. Genetic defects, both inherited or occurring spontaneously, undoubtedly play a role in increasing the susceptibility to the disorder by affecting brain development and proper neural networking. Neurological comorbidities are often observed in ASD patients and they are associated with more clinical severity. The most noted is epilepsy, comorbid in 30% of ASD, about 50 times higher than in the general population ([@B135]; [@B92]). Cognitive and behavioral deficits occurs in up to 46% of children with epilepsy ([@B29]; [@B88]) suggesting that, at least in these cases, the excitability imbalance could be a common denominator. Another comorbidity observed in nearly 90% of genetic syndromes associated with ASDs is motor delay. Delays occur in both gross and fine motor domains, while deficits are documented in praxis, motor planning, gait, coordination, and postural control ([@B104]; [@B137]). Several lines of evidence suggest that motor delay is caused by aberrant neural circuitry mostly in the cerebellum and fronto-striatal regions ([@B105]; [@B142]).

The relative risk for a child to develop the disease is increased \~25-fold in families in which a sibling is affected ([@B63]). Unfortunately, the genetic etiology of autism is characterized by high locus heterogeneity, where *de novo* and rare inherited CNVs and SNV mutations in conjunction contribute to the overall genetic risk to develop the disease. To date, we know that defined mutations, genetic syndromes and *de novo* CNVs account for about 30% of ASD cases ([@B112]). Linkage analyses of ASD patients have allowed the identification of *loss-* or *gain-of-function* mutations and chromosomal alterations in genes coding for several channel types, including K^+^ channels. These proteins are highly heterogenic and widely expressed in the CNS where they set the resting membrane potential of neurons and glia, shape action potentials and regulate firing, neurotransmitter release and wiring. At network level, K^+^ channels are involved in post-synaptic EPSP-spike coupling, activity dependent short- and long-term synaptic plasticity and information processing. Thus, these channels provide neurons, glia and CNS networks with distinct electrical identity and their dysfunction is a major contributing factor in excitability disequilibrium and network impairment. Animal models, in which these genes are deleted or mutated, often show epilepsy ([@B41]; [@B31], [@B32]), motor impairment, learning and behavioral phenotypes that resemble somehow ASD. The insights, provided by investigations with these animal models, are valuable to understand neural networks abnormalities potentially underlying ASD. The plethora of ion channel types expressed by neurons and the numerous variations discovered in their relevant genes often generate confusion in the classification of the associated diseases. To further understand the clinical subgroups of autism, help parse out distinct biological basis of autism and identify tailored treatments, we propose to name the ion channels defects contributing significantly to either monogenic or multigenic ASDs "*channelASD*" and suggest a new taxonomy (e.g., K~v~*x.y*-*channelASD and likewise* Na~v~*x.y*-*channelASD*; Ca~v~*x.y*-*channelASD; etc.*), according to a previously proposed nomenclature for ion channels dysfunctions underlying epilepsy ([@B31]). Interestingly, this review will also show that there is a high degree of clinical overlap between *channelASD* and *channelepsy*. This strong correlation between a distinct subgroup of patients prompt us to also define a new phenotype: "*channelASD-channelepsy,"* according with our previously and presently introduced nomenclature.

VOLTAGE-GATED K^+^ CHANNELS
===========================

The first voltage-gated K^+^ channel (Kv) was cloned from the *Shaker* mutant of *Drosophila melanogaster* ([@B132]). Since then, a number of other genes encoding for Kv channels have been identified from many different species. Based on sequence relatedness, Kv channels have been classified in subfamilies from Kv1 to Kv12 ([@B24]). The α subunit contains six transmembrane segments with the *N*- and *C*-termini residing inside the cell. The full crystal structure, provided for a Kv channel, confirmed that this channel is composed of four homologous pore-forming α subunits. These channels may exist either as homomers, whenever four identical α-subunits are assembled or as heteromers, whenever different types of α-subunits heteropolymerize to form channels with distinct functional and pharmacological properties ([@B99]).

K**v**4.2 -- ChannelASD
-----------------------

*KCND2* gene encodes for the α subunit of the voltage-gated K^+^ channel Kv4.2 that generates an "A-type" current (*I~A~*). When assembled in homotetramers, Kv4.2 channels activate at sub-threshold membrane potentials, inactivate rapidly, and quickly recover from inactivation ([@B152]; [@B11]). The availability of this channel type, in response to membrane potential fluctuation, is regulated by its peculiar inactivation kinetics occurring from the open state by a fast *N*-type mechanism or (*much more frequently*) from pre-open closed states, when the voltage-sensor domains activate but the pore fails to open ([@B4]; [@B45]; [@B62]; [@B6]; [@B5]). *In vivo*, other proteins further tune-up Kv4.2 inactivation kinetics: the K^+^ channel interacting protein (KChIP) and the dipeptidyl-peptidase-like protein (DPP) that respectively inhibits and accentuates N-type open state inactivation ([@B141]; [@B61], [@B60]; [@B30]). This channel type is mainly expressed in the hippocampal CA1 pyramidal neurons where it regulates the threshold for action potential initiation and repolarization, frequency-dependent AP broadening, and back-propagation of action potentials ([@B26]; [@B70]; [@B94]). These notions were further corroborated by the evidence that Kv4.2 channel deletion lowers and increases the threshold for LTP and LTD induction, respectively ([@B26]; [@B151]). Conversely, enhancement of Kv4.2 expression prevents LTP induction ([@B64]). The presence of Kv4.2 channels in hippocampus appears fundamental, mostly at early developmental stage when neuronal activity drives synaptic maturation and network refinement. At hippocampal synapses, the gradual reduction in GluN2B/GluN2A subunit ratio, during post-natal development, is correlated with AMPA expression and synaptic maturation. Ablation of Kv4.2 in mice abolished this phenomenon and resulted in a higher number of silent synapses in the adulthood ([@B67]). Noteworthy, both NMDA subunit composition and synaptic inactivity are rescued by reentering the channel ([@B67]).

Given the importance of Kv4.2 in brain development and functioning, defects of this channel have been unsurprisingly correlated with a broad spectrum of neurological disorders. Gene deletion in mice leads to increased susceptibility to convulsant stimuli ([@B7]) and truncating mutation of Kv4.2 in humans leads to temporal lobe epilepsy ([@B122]). Moreover, rare variants in *KCND2* have been identified in individuals with autism, namely: a submicroscopic *de novo* deletion ([@B96]), three translocation breakpoints (at 7q22.1, 7q31.2 and 7q31.3) potentially deleterious ([@B113]), and three substitution variants, (N544S; F538S; R539L) reported in three independent cases of autism ([@B90]). Recently, exome sequencing of two identical twins affected by autism, with frequent and uncontrollable seizures, revealed a *de novo* heterozygous variant in *KCND2* gene that resulted in the substitution V404M ([@B81]). Expression and functional characterization of Kv4.2 V404M channels in *Xenopus laevis* oocytes showed significantly slower inactivation than wild-type, leading to grater channel availability in response to depolarization. These functional alterations persisted when the mutated subunit was co-expressed with the wild-type (in 1:1 ratio to mimic the heterozygous nature of the variation), suggesting a dominant effect. The V404M impact on channel kinetics was attributed to impaired closed-state inactivation, because the effect was still evident in the presence of the auxiliary subunits KChIP3a or DPP10a ([@B81]).

K**v**4.2 -- ChannelASD linked to Fragile X syndrome
----------------------------------------------------

Kv4.2 channel expression may also participate in establishing the conditions for the development of ASDs, given that Kv4.2 mRNA can bind to the *fragile X mental retardation protein* (FMRP), which is associated to *fragile X syndrome* (FXS), the most common monogenic cause of autism and inherited intellectual retardation ([@B44]) often accompanied by seizures and poor motor coordination ([@B44]). FXS is present in \~5% of ASDs cases, and is the most likely cause of autism in those individuals. FXS is caused by an expansion of CGG triplets (\>200) in the 5^′^ untranslated region of the fragile X mental retardation gene 1 (*FMR1*), located on chromosome X ([@B73]; [@B43]), which results in the failure to produce the FMRP, required for normal neural development ([@B102]; [@B138]; [@B110]). This protein is predominantly post-synaptic, where is associated with ribosomal complexes and represses or promotes the translation of specific mRNAs ([@B125]; [@B133]; [@B150]; [@B145]; [@B93]; [@B8]). The function and localization of this protein make it a key regulator of synaptic plasticity, especially for all those activity dependent processes that require the synthesis of new proteins. In particular, FRMP appears to play a critical role in the maintenance of LTD and LTP in the hippocampus ([@B144]; [@B57], [@B56]; [@B54]; [@B78]; [@B89]). In hippocampal dendrites, FMRP is associated with Kv4.2 mRNA and prevents its translation leading to reduced channel expression at post-synaptic membrane ([@B80]). Consistent with this scenario, hippocampal neurons from *Fmr1-*null mice show higher levels of Kv4.2 protein than WT and reduced LTP, when induced by threshold stimuli ([@B80]; **Table [2](#T2){ref-type="table"}**). The application of heteropodatoxin (HpTx2), a spider toxin that specifically blocks Kv4.2 channels, restores LTP in hippocampal slices derived from *Fmr1-*null mice ([@B80]). It is therefore likely that deregulated expression of Kv4.2, resulting from FMRP-dependent abnormalities, may contribute significantly to FXS pathogenesis and generate the conditions for ASDs development.

K~**v**~7.3 -- ChannelASD
-------------------------

The K^+^ channel subunit Kv7.3 is encoded by the *KCNQ3* gene and is expressed in the hippocampus and cortex where it assembles predominantly with the homologous Kv7.2 to form "M" channels ([@B140]). Generation of functional M channels by heteropolymerization of Kv7.2(*KCNQ2*) with Kv7.4(*KCNQ4*) or Kv7.5(*KCNQ5*) subunits has also been described ([@B74]; [@B116]). This channel type was identified by [@B17] as the principal mediator of muscarine-induced depolarization. They are located in electrically critical regions of neuronal membrane, generate a typical sub-threshold K^+^ conductance and regulate the excitability of many types of neurons. In hippocampal pyramidal cells, the channel is found in the peri-somatic regions where it modulates EPSPs integration and set the threshold for EPSP-spike coupling ([@B118]). The expression of M channels is finely tuned during the development of early forms of neuronal synchrony. Indeed, in immature CA3 pyramidal cells, the "*giant depolarizing potentials*" (GDPs) exist thanks to the excitatory nature of GABA in synergy with M channel down-regulation. The progressive disappearance of GDPs, following the first postnatal week, is matched by enhancement of M current density ([@B108]) and development of more organized forms of activity, such as theta and gamma rhythms ([@B20]).

*KCNQ3* and *KCNQ2* gene mutations segregate with various forms of Kv7.3/Kv7.2-channelepsies ([@B85]; [@B31]) such as benign familial neonatal convulsion (BFNC) and rolandic epilepsy. Importantly, \>20% of patients with rolandic epilepsy have cognitive deficits and \>10% display abnormal behavioral (ADHD, anxiety, depression, and pervasive developmental disorder; [@B134]). Furthermore, 40% of patients with BFNC show delayed psychomotor development or intellectual disability ([@B128]). Several *KCNQ3* mutations, associated with BFNC, reduce heteromeric M current amplitudes ([@B124]). Mice carrying the heterozygous G311V mutation in the channel's pore show a lower threshold for epileptogenesis. While, homozygous mice exhibit spontaneous tonic--clonic seizures associated with reduced M current amplitudes and increased deactivation kinetics in hippocampal CA1 pyramidal cells ([@B123]). Interestingly, a *de novo* interstitial deletion in the long arm of chromosome 8, encompassing *KCNQ3*, has been identified in two children with a broad spectrum of congenital abnormalities, psychomotor delay and convulsions ([@B139]). Another study from [@B46] identified the *de novo* reciprocal translocation *t*(3;8)(q21, q24) truncating *KCNQ3* gene and the missense mutation P574S in distinct autistic patients. The *de novo* translocation was identified in a Danish boy affected by idiopathic periodic trembling since the age of 2 days that persisted for the first 5 weeks of life. In one case, the P574S variant, which substitutes a phylogenetically conserved residue in the *C*-terminal region of Kv7.3, was inherited from the mother who suffered from major depression. Surprisingly, none of the patients harboring this variant had histories of seizures. Functionally, the P574S variant significantly reduces K^+^ current amplitude in oocytes when co-expressed with Kv7.5 subunit but not with Kv7.2 or Kv7.4 subunits ([@B46]; **Table [1](#T1){ref-type="table"}**). Given the importance of M current in the development of neuronal identity and regulation of excitability, its impairment in immature neurons can depolarize membrane potential increasing cell excitability, facilitating the onset of seizures and delaying the definition of complex neuronal rhythms that possibly result in autistic phenotype.

###### 

Direct involvement of K^+^ channels in ASD.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene, channel, neurophysiological role                                                                                                                                    KO/cKO phenotype                                                                                                                                     Epilepsy: genetic mutation or chromosomal aberration/phenotype                                                                                                                                ASD: genetic mutation or chromosomal aberration/phenotype                                                                                                                                                                                                                                                                 Reference
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------
  ***KCND2/*Kv4.2:**\                                                                                                                                                       *-- Kcnd2*^-/-^: display increased susceptibility to convulsant stimulation.                                                                         -- Truncating mutation of Kv4.2: temporal lobe epilepsy.                                                                                                                                      -- V404M: *gain-of-function:* slows channel inactivation leading to grater channel availability in response to depolarization.\                                                                                                                                                                                           [@B26], [@B122], [@B70], [@B94], [@B7], [@B81]
  -- Neuronal: regulates the threshold for action potential initiation and repolarization, frequency-dependent AP broadening, and back-propagation of AP.                                                                                                                                                                                                                                                                                                                                                                      Found in two identical twins affected by autism, with frequent and uncontrollable seizures.                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  ***KCNQ3*/Kv7.3:**\                                                                                                                                                                                                                                                                                                            -- G311V pore mutation: benign neonatal epilepsy.\                                                                                                                                            -- *De novo* reciprocal translocation t (3; 8) (q21, q24) truncating *KCNQ3*.\                                                                                                                                                                                                                                            [@B124], [@B123]), [@B118], [@B139], [@B46]\
  -- Neuronal: generation of sub-threshold potassium current *I~M~* which, in the hippocampus, modulates EPSPs integration and set the threshold for EPSP-spike coupling.                                                                                                                                                        -- *De novo* interstitial deletion in the long arm of chromosome 8 encompassing *KCNQ3*: psychomotor delay and convulsions.                                                                   Found in one patient with delayed verbal and social development affected by idiopathic periodic trembling.\                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               -- P574S: *loss-of-function* significantly reduces potassium current amplitude in *Xenopus laevis* oocytes when co-expressed with Kv7.5 subunit but not with Kv7.2 or Kv7.4 subunits.\                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Found in three patients affected by autism.                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  ***KCNMA1*/K~**Ca**~1.1**\                                                                                                                                                -- K~Ca~1.1^-/-^ and PNs-K~Ca~1.1 ^-/-^ : display deficit in cerebellar learning, ataxia, abnormal locomotion and pronounced lack of coordination.   *-- KCNMA1 gain-of-function* mutations: cause generalized epilepsy and paroxysmal dyskinesia.                                                                                                 -- A138V: the substitution creates a cryptic splice donor site in the second exon.\                                                                                                                                                                                                                                       [@B76], [@B106], [@B119], [@B55], [@B40], [@B77], [@B147]
  -- Neuronal: negatively regulates Ca^2+^ entry and provides a damping mechanism for excitatory signals.                                                                                                                                                                                                                                                                                                                                                                                                                      Found in one patient affected by epilepsy, impairments of social interactions and communications skills, lack of spoken language and poor communicating gestures.\                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               *-- De novo* 9q23/10q22 translocation destructing *KCNMA1*: found in one patient affected by impairments of social interactions and communication skills, lack of spoken language and poor communicating gestures.                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  ***KCNJ2/*Kir2.1**\                                                                                                                                                                                                                                                                                                            -- *KCNJ2 loss-of-function* mutation: cause Andersen-Tawil syndrome a condition characterized by long QT-syndrome, cardiac arrhythmia, skeletal abnormalities, mood disorders and seizures.   -- K346T: *gain-of-function:* leads to (i) enhanced the channel's stability at the plasma membrane; (ii) reduced protein ubiquitylation and degradation; (iii) altered protein compartmentalization in lipid rafts, by targeting more channels to cholesterol-poor domains; (iv) reduced interactions with caveolin 2.\   [@B16], [@B49], [@B59], [@B23], [@B1]
  -- Glial: in combination with Kir4.1 controls astrocyte-mediated K^+^ buffering.\                                                                                                                                                                                                                                                                                                                                                                                                                                            Found in two identical twins affected by epilepsy, impaired social interaction, absence of speech, repetitive behaviors and intellectual disability.                                                                                                                                                                      
  -- Neuronal: plays an important role in DGCs firing properties during development.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  ***KCNJ10*/Kir4.1**\                                                                                                                                                      *-- Kcnj10^-/-^* : displays severe motor deficits, ipomyelinization in the spinal cord, severe spongiform vacuolation and damaged astrocytes.\       -- *KCNJ10 loss-of-function* mutations: cause EAST or SeSAME syndrome.\                                                                                                                       -- R18Q: *gain-of-function*, leads to increased channel surface expression.\                                                                                                                                                                                                                                              [@B97], [@B95], [@B39], [@B53], [@B14], [@B115], [@B103], [@B121], [@B120]
  -- Glial: potassium buffering, astrocytes and oligodendrocytes differentiation.\                                                                                          -- cKO *gfa2* directed*:* displays pronounced body tremor, lethargy and ataxia as well as visual placing deficiency and stress induced seizures.                                                                                                                                                                                                   Found in two identical twins affected by epilepsy, impaired social interaction, absence of speech, repetitive behaviors and intellectual disability.\                                                                                                                                                                     
  -- Neuronal:(regulates) expressed in *locus coeruleus* neurons                                                                                                                                                                                                                                                                                                                                                                                                                                                               -- V84M: *gain-of-function*, leads to increase channel unit conductance compared to WT.\                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Found in one patient affected by poor social gaze, no response to name, absence of language development and seizures.                                                                                                                                                                                                     
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ca^2+^-ACTIVATED K^+^ CHANNELS
==============================

The calcium-activated K^+^ (K~Ca~) channels are highly conserved across species, and widely expressed in the human brain. The phylogenetic tree of K~Ca~ channels shows that they are made of two well distinct groups ([@B143]), the large conductance (BK; K~Ca~1.1), and the small/intermediate-conductance (SK/IK; K~Ca~2.1, K~Ca~2.2, K~Ca~2.3, K~Ca~3.1) K~Ca~ channels. With regard to gating mechanism, the Ca^2+^ sensitivity of SK/IKchannels is provided by tightly bound calmodulin ([@B148]; [@B42]), in contrast to the direct binding of Ca^2+^ at specific internal sites on the channel protein of K~Ca~1.1 channels ([@B82]). Moreover, unlike the SK/IK channels, K~Ca~1.1 channels are also activated by voltage. In brain neurons, K~Ca~ channels are widely distributed in axons and presynaptic terminals ([@B71]; [@B12]), often located close to voltage-gated Ca^2+^ channels Ca~v~ ([@B86]). Ca^2+^ influx that results from neuronal excitation activates K~Ca~ channels, whose outward K^+^ flux contributes to terminate the action potential, establish the afterhyperpolarization (AHP) and close Ca~v~ channels. This negative feed-back control has been generally assumed to make K~Ca~ channels critical players in opposing repetitive firing and hyperexcitability typical of epileptic disorders. To date mutations only in the K~Ca~1.1 channel type have been clearly associated to both autism and epilepsy.

K~**Ca**~1.1 -- ChannelASD
--------------------------

The *KCNMA1* gene encodes for the α subunit of K~Ca~1.1 channel which possesses a tetrameric structure with four optional auxiliary β subunits ([@B111]). Channel activation requires both an increase in intracellular Ca^2+^ concentration and membrane depolarization ([@B130]; [@B107]). Thanks to its Ca^2+^- and voltage-dependence it negatively regulates Ca^2+^ entry and provides a damping mechanism for excitatory signals in many neuronal types. K~Ca~1.1 channels are expressed in the hippocampus, cortex and cerebellum where they contribute to both action potential repolarization and brief AHP ([@B76]; [@B106]; [@B119]; [@B55]; [@B147]). Experimentally, the contribution of presynaptic *I~KCa1.1~* is not easily detectable under basal conditions ([@B130]). It can be unmasked by blocking voltage-gated K^+^ channels with 4-aminopyridine that broadens the presynaptic action potential. Under these conditions, blocking K~Ca~1.1 channels in CA1 with *iberiotoxin* (IbTX) causes further broadening of the presynaptic compound action potential, enhancement of synaptic transmission and reduced paired-pulse facilitation ratio ([@B55]). In cerebellar Purkinje neurons (PNs), the contribution of K~Ca~1.1 channel to the AHP phase is developmentally regulated with a greater contribution in immature neurons than in adult PNs ([@B147]). *In vivo*, deletion of the *Kcnma1* gene profoundly alters cerebellar function: K~Ca~1.1^-/-^ mice show an abnormal conditioned eye blink response, abnormal locomotion and pronounced lack of coordination ([@B111]). These changes are, in part, the direct consequence of a profound disinhibition of deep cerebellar nuclei (DCN). Indeed, while all the wild-type PNs discharge spontaneous APs at baseline, 50% of K~Ca~1.1^-/-^ PNs become quiescent. Since these silent neurons have a depolarized membrane potential, a depolarization block mediated by inactivated voltage-gated Na^+^ channels has been invoked as the underlying molecular mechanism ([@B111]). Thus, K~Ca~1.1 channels ablation dramatically lowers the overall discharge activity of PNs. The close correlation between the loss of the K~Ca~1.1 channel in PNs and the cerebellar deficit was further confirmed by the genesis of PN-K~Ca~1.1^-/-^ mice, where K~Ca~1.1 expression was specifically abolished in PNs ([@B25]). These animals recapitulate the motor deficits observed in K~Ca~1.1^-/-^ mice, although to a lesser extent and show, *in vivo*, a reduction of both simple spike (SS) and complex spike (CS) activity in PNs. Recall that SS is generated by afferent parallel fibers (PF) while CS is induced by climbing fibers (CF). In these mice, the olivo-cerebellar circuit is likely deregulated since reductions in PNs inhibitory inputs result in an enhancement of DCNs activity which, in turn, exert an excessive inhibition on downstream inferior olive (IO). Interestingly, the application of muscimol (a GABA~A~ receptor agonist) onto DCN partially restores CS activity ([@B25]).

In humans, the *KCNMA1 gain-of-function* mutation D434G has been found in patients suffering from K~Ca~1.1-*channelepsy* that is characterized by generalized epilepsy and paroxysmal dyskinesia ([@B40]; [@B31]). Expression studies indicated that the D434G mutant channel results in markedly greater macroscopic currents and single-channel open probability due to \~5-fold increase in Ca^2+^ sensitivity ([@B40]). The enhancement of K~Ca~1.1 channel activity may lead to increased excitability by inducing rapid repolarization of action potentials, thus allowing neurons to fire at faster rates ([@B40]). The possible role of K~Ca~1.1 channels in ASD phenotype has been highlighted by [@B77] who have identified both the substitution A138V and the *de novo* translocation *t*(9;10) (q23; q22) in the *KCNMA1* gene of two unrelated autistic patients (**Table [1](#T1){ref-type="table"}**). The autistic patient carrying the substitution displayed epilepsy, impairments of reciprocal social interactions and communications skills, lack of spoken language and poor communicating gestures. The A138V substitution is located within the second exon of *KCNMA1* and changes a residue highly conserved in evolution from *C. elegans* to mammals. Sequence analysis showed that the substitution creates a cryptic splice donor site that likely impairs channel expression. The *de novo* translocation was found in a 6 year old boy, displaying typical symptoms of autism. The translocation separates the promoter of *KCNMA1* from the rest of the gene, leading to a non-functional allele and haploinsufficiency. In fact, the *KCNMA1* transcript levels (determined from patient's lymphoblastoid cells) were halved. In addition, patch-clamp recordings from these cells revealed depolarized Vm, increased input resistance and halved IbTX-sensitive current ([@B77]). Physiological K~Ca~1.1 channel dosage is crucial for network functionality. Indeed, either loss or gain of K~Ca~1.1 channel activity are both capable to unbalance cell excitability, markedly ([@B111]; [@B40]; [@B25]). K~Ca~1.1 *loss-of-function* mutations likely alter pyramidal neurons excitability and result in impairment of neural networks in hippocampus, an area implicated in cognition, mood disorders, and ASD. However, these mutations may also affect cerebellar PNs excitability, development, learning and memory processes, suggesting that K~Ca~1.1 channels dysfunction may impact these crucial neurophysiological processes occurring within the cerebellum and result in the psychomotor development and cognition impairments of ASD (*see below*).

K~**Ca**~1.1 -- and SLACK -- ChannelASD linked to Fragile X syndrome
--------------------------------------------------------------------

Recently, K~Ca~1.1 channels have been implicated in ASD on a different ground, since their activity is regulated by FMRP, whose mutation produces FXS. We have mentioned previously that FMRP is mainly located postsynaptically, however, important pre-synaptic functions have been recently unmasked. FMRP is present in developing growth cones of axons ([@B2]), and it has been proposed to play pre-synaptic roles in neural wiring establishment ([@B48]; [@B28]). Importantly, in pre-synaptic terminals FMRP regulates K~Ca~1.1 channel Ca^2+^ sensitivity via interactions with the channel's regulatory β4 subunit ([@B37]). Loss of FMRP, as obtained in *Fmr1*-null mice, reduces K~Ca~1.1 Ca^2+^ sensitivity leading to smaller current, AP broadening and increased short-term plasticity (STP) in hippocampal CA3 pyramidal neurons ([@B38], [@B37]; **Table [2](#T2){ref-type="table"}**). The application of IbTX, a selective inhibitor of K~Ca~1.1 channels, reproduced in WT mice the effects observed in *Fmr1-*null mice ([@B37]). In addition, *Fmr1-*null mice displayed abnormal eye-blink conditioning, atypically elongated PNs spines and enhanced LTD at PF-PNs synapses, leading to reduced PNs response to PF stimuli. The enhancement in LTD induction found in *Fmr1-*null mice was reproduced in animals where the *Fmr1* gene was ablated specifically in PNs. This more direct evidence supports the notion that intrinsic PNs defects account for altered synaptic plasticity in the cerebellum of animals lacking FMRP and the crucial role that this brain structure may play in ASDs ([@B72]).

###### 

Indirect involvement of K^+^ channels in ASD.

  Gene/channel                    Neurophysiological role                                                                                                     Regulation by FMRP                                                                                   Effect of FMRP loss at network level                                                                                     Reference
  ------------------------------- --------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------ -----------------
  ***KCND2*/K~**v**~4.2**         See: **Table [1](#T1){ref-type="table"}**.                                                                                  -- FMRP regulates K~v~4.2 mRNA translation.                                                          -- Higher K~v~4.2 expression in hippocampal neurons resulting in reduced LTP.                                            [@B69], [@B80]
  ***KCNMA1*/K~**ca**~1.1(BK)**   See: **Table [1](#T1){ref-type="table"}**.                                                                                  -- FMRP modulates Ca^2+^ sensitivity of channels via interactions with the regulatory β4 subunits.   -- Excessive AP broadening during repetitive activity, enhanced pre-synaptic Ca^2+^ influx and abnormal increased STP.   [@B38], [@B37])
  ***KCNT1*/SLACK**               -- Neuronal: contributes to the slow hyperpolarization that follows repetitive firing and regulates the rate of bursting.   -- FMRP binds to the *Slack* cytoplasmic *C*-terminal and induces an increase in channel opening.    -- Reduced *I~K(Na)~* component in MNTB neurons.                                                                         [@B10], [@B18]

Notably, FMRP can also bind to Na^+^-activated K^+^ channel *Slack*, and thus regulate its activity ([@B18]). This channel type is mainly expressed in the cortex, hippocampus, olfactory bulb and lateral MNTB neurons of the brainstem ([@B19]) where it contributes to the slow hyperpolarization that follows repetitive firing and regulates the rate of bursting ([@B10]). At the single channel level, *Slack* generates a very high conductance (\~180 pS) with frequent transitions to a relatively long-lived sub-state with a conductance about one-third that of the fully open state. The binding of FMRP to the cytoplasmic *C*-terminal of *Slack* induces a fast and dramatic effect on these channel gating properties, namely, the transition to the sub-states is almost completely abolished, and there is a marked increase in channel opening ([@B18]). In *Fmr1-KO* mice, whole-cell recording of lateral MNTB neurons shows a significantly reduced *I~K(Na)~* component compared to WT, consistent with a role for FMRP in regulating the activity of native *Slack* channels ([@B18]). Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is caused by mutations in the *CHRNA4*, *CHRNA2, CHRNB2,* or *KCNT1*(*Slack*) genes ([@B129]; [@B35]; [@B3]; [@B50]). Interestingly, intellectual disability only occurs in those patients who carry mutations in *Slack* channels ([@B50]), further suggesting a role for this channel type in both epilepsy and cognitive disorders (*reviewed in* [@B68]).

INWARDLY RECTIFYING K^+^ CHANNELS
=================================

Inwardly rectifying K^+^ (Kir) channels take their name from the greater conductance at potentials negative to *E*~K~, while at more positive values the outward flow of K^+^ ions is variably inhibited by cytoplasmic polyamines and Mg**^2+^**, by means of affinity dependent blockade. Indeed, the different sensitivity of Kir channels to polyamines and Mg**^2+^** dictates the degree of rectification from weak to strong ([@B87]; [@B83]; [@B84]; [@B126]). Cells that possess large Kir conductance display a resting membrane potential (Vm) close to *E*~K~. Beside setting the Vm values, Kir channels of excitable cells play key roles in the regulation of action potential duration and excitability. Several Kir clones have been identified and classified into seven major subfamilies, Kir1.x-Kir7.x ([@B15]; [@B51]). Structurally, a Kir subunit possesses two transmembrane domains separated by a pore-forming region, serving as the "ion-selectivity filter," with both the *N*- and *C*-termini residing inside the cell. Four subunits are assembled as both homotetramers and heterotetramers ([@B51]).

Kir2.1 -- ChannelASD
--------------------

*KCNJ2* encodes for Kir2.1 channels that possess a conductance of \~30 pS and generate macroscopic currents with strong rectification properties. High levels of *KCNJ2* transcript are found in the brain, heart and skeletal muscle. In the brain, Kir2.1 is predominantly expressed in the hippocampus, caudate, putamen, nucleus accumbens, and to lower levels in habenula and amygdala ([@B66]), where it contributes to control neuronal excitability. In particular, the amplitude of Kir2.1 currents is small in young dentate granule neurons (DGCs) and increases \~3-fold in mature DGCs to optimize their excitability. Thus, Kir2.1 channels play an important role in DGCs firing properties during development ([@B91]). Kir2.1 is also expressed in astrocytes and, in combination with Kir4.1, controls astrocyte-mediated K^+^ buffering (*see below*; [@B16]; [@B59]; [@B27]). *Loss-of-function* mutations in the *KCNJ2* gene are responsible for the rare Andersen-Tawil syndrome (OMIM 170390) a condition characterized by long QT-syndrome, cardiac arrhythmia, skeletal abnormalities, periodic paralysis, mood disorders, and seizures ([@B49]; [@B23]). Conversely, Kir2.1 *gain-of-function* mutations segregate with SQT3 syndrome (OMIM 609622), another cardiac disorder characterized by QT shortening, ventricular tachyarrhythmias and atrial fibrillation. Indeed, in the heart Kir2.1 is a component of the inward-rectifier current IK1, which provides substantial repolarizing current during the terminal repolarization phase of the cardiac action potential and is the primary conductance controlling the diastolic membrane potential ([@B58]; [@B109]).

Recently, we reported on the identification of a new K346T heterozygous mutation in the *KCNJ2* of monozygotic twins displaying autism and epilepsy *in cis* with the previously detected R18Q variant in *KCNJ10* ([@B121]; [@B1]; **Table [1](#T1){ref-type="table"}**). The twins also showed an electrocardiogram (ECG) with a markedly short repolarization time and conspicuously narrow and peaked T waves (QTc interval, 331 ms). K346T expression resulted in larger homozygous and heterozygous K^+^ currents due to increased surface expression of the channel in oocytes, HEK293 and glial-like cells. Functionally, several deleterious defects were also described for this novel *KCNJ2* variant which: (i) enhanced the channel's stability at the plasma membrane; (ii) reduced protein ubiquitylation and degradation; (iii) altered protein compartmentalization in lipid rafts, by targeting more channels to cholesterol-poor domains; (iv) reduced interactions with caveolin 2. All these molecular mechanisms contributed to causing Kir2.1 *gain-of-function*. Notably, the mutation promotes the surface expression of the channels particularly at end-feet, filopodia-like structures and cell--cell contacts. These structures are essential for astrocyte-mediated K^+^ siphoning through Kir2.1, Kir4.1, and Kir5.1 channels, all of which could be influenced by the K346T mutation. Given that Kir2 channels also contribute to regulating neuronal excitability, cell differentiation, synaptic plasticity and wiring, their dysfunction may impact these crucial neurophysiological processes. Therefore, this study proposed that genetically induced Kir2.1 defects, beside causing SQT3 syndrome, may possibly result in functional impairment of neural networks where this channel type resides and contributes to ASDs pathogenesis ([@B1]).

Kir4.1 -- ChannelASD
--------------------

The *KCNJ10* gene encodes for Kir4.1 channels ([@B15]), which forms homomeric channels or polymerize with Kir5.1 (*KCNJ16*) to form heterotetramers ([@B101]) highly sensitive to pH ([@B136]; [@B100]; [@B21]; [@B34]). Kir4.1 is mainly expressed in *locus coeruleus* neurons, oligodendrocytes and astrocytes surrounding synapses and blood vessels from cortex, thalamus, hippocampus, and brainstem ([@B131]; [@B52]; [@B34]). In these cells, Kir4.1 channels generate high K^+^ permeability driving the membrane potential near E~K~ values. During excitatory synaptic activity, astrocytes surrounding synapses slowly depolarize because of K^+^ influx across their membranes ([@B97]). This prolonged inward K^+^ current is mediated mainly by Kir4.1 and is synchronized with synaptic and spiking activity ([@B120]). Thanks to the functional coupling between neurons and astrocytes the excess of extracellular K^+^ ions, resulting from intense neuronal firing, is taken up by astrocytes by flowing through Kir4.1 channels. Then, K^+^ ions are transferred toward sites where their concentration is kept at low levels by the gap-junction cell-syncytium ([@B75]). By this mechanism, known as "*K^+^ siphoning,*" the concentration of extracellular K^+^ in CNS is strictly ruled about 2--3 mM, avoiding neuronal after-discharges and depolarization block. In the mouse hippocampus, Kir4.1 is significantly up-regulated between P3 and P12 ([@B117]) and its expression is closely related to cell differentiation. In fact, Kir4.1 channels are absent in immature proliferating cells of the glia, and its progressive expression is linked to astrocytes hyperpolarization, differentiation and exit from cell cycle (from G2/M to G0/G1; [@B53]). Genetic ablation of Kir4.1 in rodents results in severe motor deficits, hypomyelination in the spinal cord, severe spongiform vacuolation, astrocytes with immature morphology and premature death before P24 ([@B95]). Conditional ablation of Kir4.1, exclusively in astrocytes, resulted in a mouse phenotype characterized by pronounced body tremor, lethargy, ataxia as well as visual placing deficiency and stress-induced seizures ([@B39]). In humans, *KCNJ10 loss-of-function* mutations segregate with the EAST or SeSAME syndrome, a rare autosomic recessive disorder characterized by epilepsy, ataxia, sensorineural deafness, and tubulopathy. The patients develop tonic--clonic seizures in infancy followed by motor delay, speech and mental retardation ([@B14]; [@B115]; [@B103]). In line with the pathophysiological relationship between the Kir4.1 channel impairment and both epilepsy and developmental disorders, we investigated the frequency of *KCNJ10* mutations in several children with cryptogenic epilepsy and autism spectrum traits. We found two inherited heterozygous *KCNJ10* mutations at residues highly conserved in mammalian and vertebrate orthologs: R18Q in two identical twins and V84M in another child. The expression of mutant channels in *Xenopous laevis* oocytes resulted in current/voltage relationships with greater amplitudes than WT for both mutations, suggesting a *gain-of-function* effect. Patch-clamp single-channel recordings revealed that the V84M mutation increased the unit conductance \~1.5 fold compared to WT. The R18Q mutation altered neither the unit conductance nor the single channel parameters, yet increased the channel surface expression. Clinically, the two identical twins showed impaired social interaction, sleep difficulties, hypotonia and both exhibited epileptic spasms occurring within the same 24 h period. Other symptoms, typical of ASD, included clumsiness, absence of speech, severe disorder of social interaction, stereotypies, repetitive behaviors, symptoms of anxiety, depression, obsessive compulsive disorder and intellectual disability (IQ: 58). The child harboring the V84M mutation showed normal psychomotor development until 12 months of age, when ASD symptoms such as poor social gaze, no response to name, absence of language development, and withdrawal behaviors became evident. At the age of six, he experienced complex partial seizures. EEG recordings showed synchronous and asynchronous paroxysmal abnormalities over frontal regions in both hemispheres, tending to spread ([@B121]; **Table [1](#T1){ref-type="table"}**). Co-occurrence of epilepsy and ASD in patients harboring *KCNJ10 gain-of-function* mutations suggests that dysfunction in the astrocytic-dependent K^+^ buffering may be a common mechanism contributing to seizures as well as the core behavioral features of ASD. Kir4.1 *gain-of-function* mutations may lead to faster and larger influx of K^+^ into astrocytes, during intense neuronal activity, resulting in membrane depolarization and higher intracellular Ca^2+^ elevations in these cells. Ca^2+^ elevations in astrocytes are associated with gliotransmitters' release, such as glutamate and D-serine that trigger discharges in neurons and promote local neuronal synchrony and epileptic activity ([@B127]). Abnormal synaptic function is the common basis for ASDs. Inasmuch as the activity of many thousands of synapses is controlled by a single astrocyte and this cell type makes up 90% of all human brain cells, defective astrocyte-dependent CNS development and regulation of K^+^ homeostasis in the brain represent original mechanistic hypotheses linking the allelic variations we have identified in *KCNJ2* and *KCNJ10* and ASD.

ChannelASD-CHANNELEPSY PHENOTYPE
================================

Mutations in K^+^ channels have been widely associated with several forms of channelepsies ([@B31]). The analysis of the literature performed here shows that in nearly all cases affected by K^+^ channelASDs, epilepsy is always comorbid. The degree of clinical and genetic overlap between K^+^ channelASDs and some K^+^ channelepsies, suggests that a subcategory named *channelASD-channelepsy phenotype* may be distinguished. Indeed, this scenario could be envisioned for some other channel types, playing significant roles in brain development, behavior and cognition. An effective example in this direction comes from Dravet's syndrome (DS), a devastating neurodevelopmental disorder ([@B22]; [@B36]). DS is characterized by comorbidity of epilepsy and psychiatric disorders, and linked to Nav1.1(*SCN1A*) channel dysfunction. Indeed, together with early-life intractable seizures, patients develop devastating psychomotor, cognitive and behavioral deficits persisting through adulthood ([@B9]). Thus, *SCN1A* has been suggested as a candidate gene for ASD ([@B146]). The implication of this gene was confirmed by whole-exome sequencing of sporadic ASD cases that revealed a missense mutation in a severely affected patient with evidence of early onset, language delay, epilepsy, and mild intellectual disability. This mutation leads to replacement of the highly conserved proline 1894 with lysine, and is predicted to be functionally deleterious ([@B98]). *Scn1a^-/+^* rodents recapitulate DS ([@B149]; [@B65]). The loss of Nav1.1 channels, which is mostly expressed in GABA*ergic* interneurons, leads to a marked reduction in the inhibitory activity of these cells that reverberates onto prefrontal and hippocampal pyramidal neurons, which consequently fire at higher frequencies ([@B47]). Remarkably, these mice show epilepsy and a spectrum of behavioral abnormalities characteristic of ASD such as hyperactivity, anxiety, altered behavioral interaction and deficits in context-dependent spatial memory ([@B149]; [@B47]). Thus, it could be possible to hypothesize that distinct channel-dependent autism/epilepsy cases share a common etiopathological denominator, namely an excitatory-inhibitory imbalance generating a non-permissive substrate for the physiological development of the proper cognitive and behavioral skills, resulting in *channelASD-channelepsy phenotype.*

CONCLUDING REMARKS
==================

Autism spectrum disorders are amongst the most common neuropsychiatric diseases ([@B13]) that show increasing prevalence over the past years and no discrimination in terms of ethnicity, family income or educational levels. However, how much of this increase is due to a broader definition of ASD and better efforts in diagnosis or an effective increased incidence of the disorders, is unclear. The number of ASDs cases that could be accounted for a channel-dependent pathogenesis and classified in the *channelASD* subgroup, remains to be established. Inasmuch as \~70 million people suffer from ASD and nearly 500 ion channel proteins are encoded by the human genome, the worldwide number of *channelASD* cases might not be negligible.

Despite the efforts made, the etiology of ASD remains largely elusive because many cases arise from a mixture of multiple environmental and genetic factors. In addition, the modalities by which the combinations of different genetic variations contribute to the overall risk to develop the disease are mostly obscure. Nevertheless, a mounting body of evidence indicates that ion channel dysfunction may well enhance autism susceptibility ([@B114]) also when other contributing alleles are co-inherited. Direct and indirect defects in K^+^ channels have been implicated in ASDs pathogenesis, likely altering crucial neural network processes in several brain areas including the cerebellum, a structure that emerges as critically involved in determining the core features of ASDs. Abnormal synaptic transmission and dendritic spine pathology play crucial roles in ASDs. Notably, the activity of many thousands synapses is controlled by a single astrocyte. Thus, aberrant astrocyte-dependent synaptic functions and CNS development, induced by defective ion channels, represent an interesting causative hypotheses for ASDs ([@B33]; [@B121]; [@B1]). Undeniably, the high heterogeneity of ASDs makes the solution of the "*autism puzzle*" an extremely difficult task. Notwithstanding, to ensure the best possible outcomes for children affected by this devastating disease, comprehensive socio--economic policies and coordinated scientific efforts are required as a matter of urgency.
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